1683.4500 6.60 (0.39%)
NSE Mar 13, 2025 15:31 PM
Volume: 1.7M
 

1683.45
0.39%
ICICI Securities Limited
Sun Pharma (Sun) is acquiring US-based early-stage oncology-focused biotech company Checkpoint Therapeutics (Checkpoint) for an upfront cash payment of USD 4.1/share (total outgo of USD 355mn) and USD 0.7/share in cash in future milestones.
ICICI Securities Limited upgraded Sun Pharmaceutical Industries Ltd. to Buy with a price target of 1895.0 on 11 Mar, 2025.
More from Sun Pharmaceutical Industries Ltd.
Recommended